- Exchange: New York
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Large Pharmaceuticals
Snapshot for Pfizer Inc (PFE)
| Open: | 29.3700 | Day's Range: | 28.9000 - 29.8100 | Volume: | 121,044,185 |
|---|---|---|---|---|---|
| Previous Close: | 29.4000 | 52wk Range: | 22.0000 - 31.1500 | 1-Yr Rtn: | +32.96% |
Key Statistics for PFE
| Current P/E Ratio (ttm) | 13.5066 |
|---|---|
| Estimated P/E(12/2013) | 13.1913 |
| Relative P/E vs. SPX | 0.8464 |
| Earnings Per Share (USD) (ttm) | 2.1545 |
| Est. EPS (USD) (12/2013) | 2.2060 |
| Est. PEG Ratio | 3.1163 |
| Market Cap (M USD) | 206,412.80 |
| Shares Outstanding (M) | 7,093.22 |
| 30 Day Average Volume | 63,648,168 |
| Price/Book (mrq) | 2.5107 |
| Price/Sale (ttm) | 3.7161 |
| Dividend Indicated Gross Yield | 3.30% |
| Cash Dividend (USD) | 0.2400 |
| Last Dividend | 05/08/2013 |
| 5 Year Dividend Growth | -5.49% |
| Next Earnings Announcement | 07/31/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for PFE
Company Profile & Key Executives for PFE
Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
| Ian C ReadChairman/CEO | Olivier BrandicourtPres & Gen Mgr:Emerging Market |
| John D YoungPres & Gen Mgr:Primary Care | Geno J GermanoPres & Gen Mgr:Specialty Care |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
PFE News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page